Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)
A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement in the Prevention of Lymphedema Following Locoregional Treatment for Breast Cancer (PREVENT)
Sponsor: ImpediMed Limited
This NA trial investigates Lymphedema and is currently completed. ImpediMed Limited leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Oct 2018 — Aug 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Jul 2017 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ImpediMed Limited
- Macquarie University, Australia
- Vanderbilt University
For direct contact, visit the study record on ClinicalTrials.gov .